This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Adjusting your budget monthly helps you stay aligned with your financial goals. Explore the benefits of this practice for better control.
23,559 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The crypto market kicked off 2026 with volatility, but three tokens jumped 25% or more. Dive into what drove these ga...
When bad news hits a stock, investors ask if it’s a bargain. This piece weighs UPS’s challenges against its resilient...
Warren Buffett famously bailed on airlines in 2020. Now Berkshire Hathaway backs Delta with a multi-billion stake, si...
Mercadolibre stock down strong after a mixed reaction to solid quarterly results. This article breaks down why growth...
Berkshire Hathaway is positioned to become a much larger Alphabet holder as the tech giant pursues a bold AI financin...
When a network equipment company taps the market for capital, a stock pullback often follows. Here’s a clear, investo...
Oracle stock dips despite a swelling backlog. This guide explains what backlog means, why the stock reacts, and how i...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...
The data center build-out accelerating wave is reshaping where investors place bets. Beyond chips, three infrastructu...
A fierce bidding war over Two Harbors tested UWM's strategy. This article explains why UWM walked away from harbors c...
Circle Internet Group sits at the crossroads of digital money and mainstream finance. In this deep dive, we break dow...